- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03887104
Data Collection of OCT and OCTA-based Ocular Measurements
August 30, 2019 updated by: Optovue
Data Collection of OCT and OCTA-based Ocular Measurements
Study Overview
Detailed Description
The purpose of this study is to collect measurements of anatomical structures of the posterior pole of the eye based on OCT scans in subjects without clinical signs of pathology.
Study Type
Observational
Enrollment (Actual)
482
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Pomona, California, United States, 91766
- Eye Care Center
-
-
Florida
-
Fort Lauderdale, Florida, United States, 33312
- Eye Care Institute
-
-
New Jersey
-
Newark, New Jersey, United States, 07103
- IOVS
-
-
Ohio
-
Marysville, Ohio, United States, 43040
- AMA Eye Physicians & Surgeons
-
-
Oklahoma
-
Tahlequah, Oklahoma, United States, 74464
- College of Optometry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Persons having eyes without ocular pathology
Description
Inclusion Criteria:
- No glaucoma
- No retinal pathology
- No systemic disorders impacting the eye
- No ocular surgery or medical treatment of ocular condition
Exclusion Criteria:
- High IOP
- Poor vision
- Clinical findings consistent with pathology
- Unable to complete the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retinal thickness
Time Frame: Day 1
|
micrometers
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2019
Primary Completion (Actual)
July 11, 2019
Study Completion (Actual)
August 30, 2019
Study Registration Dates
First Submitted
March 11, 2019
First Submitted That Met QC Criteria
March 20, 2019
First Posted (Actual)
March 22, 2019
Study Record Updates
Last Update Posted (Actual)
September 3, 2019
Last Update Submitted That Met QC Criteria
August 30, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 200-53771
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eyes Without Ocular Pathology
-
OptovueCompletedNormal Eyes and Eyes With Ocular PathologiesUnited States
-
OptovueCompletedNormal Eyes and Ocular PathologyUnited States
-
OptovueCompleted
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Jadran Galenski laboratorij d.d.CompletedPrimary Open Angle Glaucoma of Both EyesRussian Federation
-
Jadran Galenski laboratorij d.d.CompletedPrimary Open Angle Glaucoma of Both EyesRussian Federation
-
Duke UniversityCompletedMaculopathy | Hypotony Ocular | Cornea Folds and Rupture of Bowman's Membrane Both EyesUnited States
-
Western University, CanadaCompletedOcular Hypertension | Intraocular Pressure | Primary Open Angle Glaucoma of Both EyesCanada
-
Qlaris Bio, Inc.CompletedPrimary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)United States
Clinical Trials on SD-OCT
-
Queen's University, BelfastCompletedGlaucomaUnited Kingdom
-
University of ZurichUnknownGlaucoma | CataractSwitzerland
-
Centre Hospitalier Intercommunal CreteilWithdrawn
-
OptovueCompletedNormal Eyes and Eyes With Ocular PathologiesUnited States
-
Pusan National University HospitalCompletedGlaucoma | Tomography, Optical CoherenceKorea, Republic of
-
OptovueCompleted
-
University Hospital, BordeauxCompleted
-
Universidade do PortoCentro Hospitalar Universitário de Santo António; Faculty of Medicine (FMUP)RecruitingLupus Erythematosus, Systemic | Eye ManifestationsPortugal
-
Duke UniversityOptovueTerminatedDiabetic Retinopathy | Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular DegenerationUnited States
-
Centre Hospitalier Intercommunal CreteilCompleted